Epiminder (ASX:EPI) Total Liabilities: A$4.08 Mil (As of Dec. 2025)


ASX:EPI Epiminder Ltd ASX:EPI
17 GF Score
Price A$0.32
View Full Analysis

What is Epiminder Total Liabilities?

Epiminder ASX:EPI +1.59% 17 Total Liabilities is A$4.08 Mil as of Dec. 2025. GuruFocus rates ASX:EPI with a GF Score™ of 17/100.

Epiminder's Total Liabilities for the quarter that ended in Dec. 2025 was A$4.08 Mil.

Epiminder's quarterly Total Liabilities increased from Jun. 2024 (A$0.00 Mil) to Jun. 2025 (A$23.32 Mil) but then declined from Jun. 2025 (A$23.32 Mil) to Dec. 2025 (A$4.08 Mil).

Epiminder's annual Total Liabilities stayed the same from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil) but then increased from Jun. 2024 (A$0.00 Mil) to Jun. 2025 (A$23.32 Mil).

Epiminder Total Liabilities Historical Data

* Premium members only.

The historical data trend for Epiminder's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epiminder Total Liabilities Chart

Epiminder Annual Data
Trend Jun23 Jun24 Jun25
Total Liabilities
0.00 0.00 23.32

Epiminder Semi-Annual Data
Jun23 Jun24 Jun25 Dec25
Total Liabilities 0.00 0.00 23.32 4.08
ASX:EPI
17GF Score
Epiminder Ltd ASX:EPI
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epiminder Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Epiminder's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=23.212+(0+-5.6898930012039E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.11+0)
=23.32

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=130.707-107.385
=23.32

Epiminder's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.926+(0+0.157
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.08

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=104.353-100.27
=4.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of A$4.08 Mil mean?
Epiminder (ASX:EPI) has a Total Liabilities of A$4.08 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Epiminder and its competitors.
Is Epiminder's Total Liabilities too high?
Epiminder's current Total Liabilities is A$4.08 Mil. Overall, Epiminder has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Epiminder's Total Liabilities compare to ABT and SYK?
Epiminder's Total Liabilities of A$4.08 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Epiminder and its competitors. Epiminder's current Total Liabilities is A$4.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epiminder stock overvalued right now?
Epiminder (ASX:EPI) has a current Total Liabilities of A$4.08 Mil. The current Total Liabilities is A$4.08 Mil. Epiminder's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Epiminder (ASX:EPI), the current Total Liabilities is A$4.08 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epiminder Business Description

Address 525 Collins Street, 210 West Podium, Mezzanine 2, Melbourne, VIC, AUS, 3000
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
17GF Score

Get the complete analysis for ASX:EPI

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.32
Price